Benefit of including CT urography in 68Ga-PSMA-11 PET/CT with low-dose CT: first results from a larger prostate cancer cohort analysis.
CONCLUSIONS: CT urography benefits the interpretation of 68Ga-PSMA-11 PET/CT with low-dose CT and leads to discrepant patient treatment in a small but significant subset of patients (12% in our cohort). The implementation of CT urography into standard protocols of 68Ga-PSMA-11 PET/CT with low-dose CT is recommended.
PMID: 31992688 [PubMed - as supplied by publisher]
Source: Quarterly Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Tags: Q J Nucl Med Mol Imaging Source Type: research
More News: Cancer | Cancer & Oncology | Nuclear Medicine | Prostate Cancer | Study | Ureter and Renal Pelvis Cancer | Urography